Want to see BDSX full AI Analyst Report?
Revenue by Segment
Shows how much revenue each business unit or product line generates, highlighting areas of strength and potential growth within the company’s portfolio.Diagnostic testing is the clear growth engine—volume-driven expansion plus modest ASP gains are lifting top-line momentum and gross margins, supporting the raised 2026 guide; primary‑care adoption and a bigger salesforce make that ramp look repeatable. Development services are becoming a meaningful, backlog-backed second leg but remain timing‑sensitive and add quarter-to-quarter volatility. Execution risk (sales productivity, logistics, collections) and limited cash mean converting this momentum into sustained profitability is the key investor watchpoint.
Date | Diagnostic Tests | Development Services |
|---|---|---|
Jun 30, 2026 | $25.35M | $1.51M |
Mar 31, 2026 | $22.29M | $3.26M |
Dec 31, 2025 | $25.15M | $3.61M |
Sep 30, 2025 | $19.84M | $1.93M |
Jun 30, 2025 | $17.90M | $2.12M |
Mar 31, 2025 | $16.32M | $1.64M |
Dec 31, 2024 | $17.20M | $3.22M |
Sep 30, 2024 | $17.17M | $983.00K |
Jun 30, 2024 | $16.54M | $1.39M |
Mar 31, 2024 | $13.80M | $1.02M |